Epigenetic analysis of regulatory T cells using multiplex bisulfite sequencing by Rainbow, Daniel B et al.
3200 Daniel B. Rainbow et al. Eur. J. Immunol. 2015. 45: 3200–3203DOI: 10.1002/eji.201545646
Technical comment
[DOI: 10.1002/eji.201545646]
Epigenetic analysis
of regulatory T cells
using multiplex
bisulfite sequencing
A subset of regulatory CD4+ T cells (Tregs)
is characterized by the stable constitu-
tive expression of the transcription fac-
tor FOXP3. Demethylation at a conserved
region within intron 1 of FOXP3, the Treg-
specific demethylated region (TSDR), is
exclusive to this subset of Tregs: other
immune cells that do not express FOXP3
or express the transcription factor tran-
siently, such as activated effector T cells
or TGF-β-treated CD4+ T cells, are methy-
lated at the TSDR [1–4]. Hence, the TSDR
provides a specific target to enumerate
Tregs within biological samples; develop-
ing methods that enable robust Treg-cell
quantitation with small numbers of cells
from clinical samples remains an important
goal. Current methods to measure FOXP3
demethylation include qPCR [5, 6] and
epigenetic sequencing methylation analy-
sis [7] of Sanger sequencing traces [8],
neither of which capture the methylation
information at each CpG site on a sin-
gle piece of DNA, but rather produce an
average methylation over the whole region
or an average at each site. Although sev-
eral studies have used a PCR cloning and
sequencing method to assess the methyla-
tion of each CpG site within the TSDR, this
is a laborious method and normally less
than 50 clones per sample are analyzed
[3, 9, 10].
We therefore developed a next-
generation sequencing (NGS) method to
assess at single-base resolution the methy-
lation status of the FOXP3 TSDR. The
method, which we originally developed
to genotype rs1800521 single nucleotide
polymorphism in the gene AIRE (Meth-
ods detailed as Supporting Informa-
tion), reports at single base resolution
the methylation of each DNA ampli-
con, provides hundreds to thousands of
reads per replicate and can be multi-
plexed to analyze several DNA regions
simultaneously.
Our method uses two-stage PCR: the
first is a gene-specific PCR with primers
having an adaptor sequence that is tar-
geted by a second round PCR, which
adds a unique index sequence enabling
up to 960 different samples to be pro-
cessed per sequencing run. We targeted
nine CpG sites within the TSDR (Sup-
porting Information Fig. 1), which have
also been used in qPCR assays [6]. Our
primers flank the TSDR alleviating the
need for methylation-specific primers as
well as the demethylated and methy-
lated standards required in qPCR assays.
We also developed a bioinformatics pro-
cessing pipeline that reads the raw out-
put from sequencing and reports the
methylation status at each CpG (https://
github.com/XinYang6699/Methpup). To
validate our method, we sequenced the
TSDR in three CD4+ T-cell subsets, Tregs
and na¨ıve andmemory effector cells, which
were defined by surface molecules CD4,
CD25, CD127 [11] and purified by flow
sorting from two male and two female
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donors (Fig. 1, Supporting Information Fig.
2, Supporting Information Table 1). We
observed a linear relationship between the
proportion of Tregs and the proportion of
FOXP3 demethylation in defined mixtures
of Tregs and na¨ıve CD4+ T cells (r2 = 0.99,
Supporting Information Fig. 3). Cell inputs
below 2000 cells/PCR replicate showed
increasing assay variation so unless cells
are extremely limiting, we typically utilize
2000–4000 cells per replicate and six repli-
cates per cell sample (Supporting Informa-
tion Fig. 4).
As expected based on previous publi-
cations where the TSDR was shown using
multiple technologies to be demethylated
in a majority of Tregs [1, 3, 8], 86% and
62%of the TSDR sequences were demethy-
lated in Treg samples from male donors
and 44% and 40% from female donors
(Fig. 1, Supporting Information Fig.
2, Supporting Information Table 1).
Owing to X inactivation, demethylation
of the FOXP3 TSDR occurs on only one
copy of the X chromosome in females
thereby explaining the 50% lower
demethylation level as compared to males.
Although in Tregs the majority of highly
demethylated sequencing reads are
demethylated at all nine CpG sites con-
sidered, a proportion (<10%) of reads
have only eight CpG sites demethylated.
This incomplete demethylation could be
due to biological effects or to incomplete
bisulfite conversion. We favor the former
possibility since bisulfite conversion effi-
ciency as determined by cytosines that
cannot be methylated was greater than
99% (Supporting Information Fig. 5A).
Underscoring this biological heterogene-
ity, in na¨ıve and memory effector cells
demethylation of a single CpG among
the nine sites was observed at each
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Figure 1. FOXP3 TSDR sequencing of puri-
fied human CD4+ T-cell subsets. (A) Naı¨ve
(CD4+, CD127+, CD45RA+, CD62L+) and mem-
ory (CD4+, CD127+, CD45RA−, CD62L+) effec-
tor cells and Tregs (CD4+, CD25+, CD127−) were
sorted from a male (B) and a female (C) donor
by flow cytometry and analyzed for FOXP3
TSDR methylation (two representative donors
out of a total of four, for more information
see Supporting Information Fig. 2 and Sup-
porting Information Table 1). See Supporting
Information Fig. 7 for gating strategy defin-
ing CD4+ TCRαβ+ T cells. The x axis shows
the nine methylation sites analyzed and each
row indicates the methylation status of one
copy of the sequenced TSDR. Light green rep-
resents a C (methylated) and dark green rep-
resents a T (demethylated). The y axis is the
percentage of sequencing reads for each
methylation/demethylation pattern. Six repli-
cates of 3000 cells per replicate (5 ng DNA)
were analyzed from a single donor and the
median (with range) reads with eight or nine
sites demethylated at FOXP3 for the replicates
is shown below each graph. (D) A schematic
of the FOXP3 gene and the TSDR sequence are
shown.
position interrogated and, when com-
bined, comprised 20% of the reads.
Thus the use of NGS to quantify demethy-
lation has the advantage of revealing
heterogeneity inherent in the biological
process of gene regulation. As expected,
and in contrast to Tregs, less than 2% of
the TSDR reads from na¨ıve and memory
effector cells had a Treg-like TSDR methy-
lation pattern. Although this low level of
Treg-specific sequences could be caused
by suboptimal cell purification, Tregs with
low levels of surface CD25 and a demethy-
lated TSDR have been reported [12] and
could account for the low percentage of
Treg-specific reads observed in effector
T-cell subsets sorted by cell surface mark-
ers. The NGS-based demethylation assay
offers a great advantage in detecting small
subpopulations of cells demethylated at
the FOXP3 TSDR as compared to methods
that generate an average demethylation
status at each residue since each NGS read
simultaneously assesses the methylation
status of all CpG sites from a single copy
of the gene giving confidence in the
interpretation of a demethylated read.
Further characterization of rare subsets
requires more detailed sorting in future
studies including intracellular staining of
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Figure 2. CTLA4 demethylation in human FACS-purified cells. Cells were purified and analyzed as detailed in Fig. 1 for CTLA4 methylation status.
The median (with range) reads with all seven sites demethylated at CTLA4 for the replicates is shown below each graph. Data are representative
of four donors (for more information see, Supporting Information Fig. 2 and Supporting Information Table 2).
FOXP3, a procedure that is compatible
with NGS-based analysis of bisulfite
converted DNA [13].
Because the current version of our NGS
sequencing platform utilizes up to 960
unique index sequences per sequencing
run of approximately 20 million reads,
each index is associated with approx-
imately 20 000 reads. In most cases,
20 000 reads per replicate is in excess of
what is required for robust measurements
of percent demethylation of any particu-
lar region thereby allowing for the multi-
plexing of gene regions within the same
sample. We used multiplexing of up to
six gene regions to search for an autoso-
mal TSDR since female samples have 50%
less demethylated FOXP3 TSDR reads than
male samples. In mouse studies, specific
regions in multiple genes in addition to
Foxp3 were identified that showed Treg-
specific demethylation when compared to
conventional CD4+ T cells analyzed ex
vivo: Ctla4, Il2ra, Gitr, Eos, and Helios
[9]. In comparing the human and mouse
sequences in the regions reported, only
one strong homology was observed, that
in exon 2 of mouse Ctla4 and human
CTLA4 (Supporting Information Fig. 6).
We developed a sequencing assay for this
region in the human gene, multiplexed
with the FOXP3 TSDR sequencing assay,
and demonstrated that demethylation of
exon 2 of human CTLA4 is not Treg-
specific. Although>90% of Tregs analyzed
ex vivo were demethylated at all seven
CpG sites examined, 21–38% of memory
CD4+ T cells were demethylated at these
same sites (Fig. 2, Supporting Information
Fig. 2, Supporting Information Table 2). In
addition, memory effector cells displayed a
heterogeneous demethylation pattern with
37–48% of reads having an intermediate
methylation pattern (3T, 4T, 5T, or 6T).
Thus demethylation of the human CTLA4
exon 2 region reflects more than Treg lin-
eage commitment.
To conclude, we developed a high-
throughput method for analyzing methy-
lation at single CpG resolution that uses
low DNA input and can be multiplexed.
Although we have used the method to
measure Treg-specific methylation, it can
be easily adapted to verify genome-wide
methylation results. Finally, given recent
data showing that many disease-associated
SNPs are located in enhancer regions [14],
the presence of allele-specific methyla-
tion detected using our high-throughput
method could provide a mechanism for
disease-associated gene regulation.
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